Shares in drug firms GlaxoSmithKline and Sanofi surged after a US judge dismissed thousands of lawsuits claiming that the heartburn drug Zantac caused cancer.
GSK’s shares jumped as much as 14% in early trading, while Sanofi’s stock jumped nearly 6% in mid-morning trading.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,